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Abstract.  The adhesion of embryonic chicken retinal 
cells and mouse N2A neuroblastoma cells to purified 
embryonic chicken retinal  NCAM adsorbed on a  solid 
substratum was examined using a quantitative centrifu- 
gal adhesion assay.  Both cell types adhered to NCAM 
and the adhesion was specifically inhibited by monova- 
lent anti-NCAM antibody fragments.  N2A cell adhe- 
sion depended on the amount of NCAM applied to the 
substratum,  was cation independent,  and was insensi- 
tive to treatment with the cytoskeletal perturbing 
drugs colchicine and cytochalasin D.  These results in- 
dicated that the tubulin and actin cytoskeletons were 
not critically required for adhesion to NCAM and 
make it unlikely that the cell surface ligand for 
NCAM is an integrin.  Adhesion was however tempera- 
ture dependent,  strengthening  greatly after a brief in- 
cubation at 37~  CHO cells transfected with NCAM 
cDNAs did not adhere specifically to substratum- 
bound NCAM and pretreatment of N2A cells and reti- 
nal cells with anti-NCAM antibodies did not inhibit 
adhesion to substratum-bound NCAM. These results 
suggest that a heterophilic interaction between 
substratum-adsorbed NCAM and a non-NCAM ligand 
on the surface of the probe cells affects adhesion in 
this system and support the possibility that heter- 
ophilic adhesion may be a function of NCAM in vivo. 
T 
HE neural  cell adhesion molecule NCAM  L  is a verte- 
brate cell surface glycoprotein that is involved in cell- 
cell adhesion both in vivo and in vitro (Brackenbury 
et al.,  1977; Thiery et al.,  1977; Rutishauser  et al.,  1982, 
1983, 1988; Sadoul et al.,  1983; Fraser et al.,  1984; Keil- 
hauer et al.,  1985; Cole et al.,  1986b;  Thor et al.,  1987; 
Kadmon et al.,  1990). NCAM is expressed in developmen- 
tally regulated patterns on a variety of neural and nonneural 
tissues (Thiery et al., 1982; Crossin et al., 1985; Pollerberg 
et al., 1985). A prerequisite for evaluating the physiological 
significance of adhesion mediated by this molecule is to un- 
derstand the cellular and molecule mechanisms underlying 
the adhesion process. 
Initial studies showed that preincubation of  either adhesion 
partner with anti-NCAM antibody fragments  could inhibit 
cell-monolayer or cell-substratum binding  (Rutishauser  et 
al., 1982; Cote et al., 1985) and that the aggregation of mem- 
brane vesicles containing purified NCAM could be inhibited 
specifically  by anti-NCAM  antibody  fragments  (Hoffman 
and Edelman,  1983). These studies  suggested that NCAM- 
mediated adhesion involves homophilic interactions between 
two NCAM molecules on apposed cells. Other studies, how- 
ever, seem less consistent with a simple homophilic mecha- 
nism for NCAM-mediated adhesion.  Transfectants  express- 
ing exogenous cell surface NCAM adhere poorly to each 
other (Edelman et al., 1987; Pizzey et al., 1989; Reyes et al., 
1. Abbreviation used in this paper: NCAM, neural cell adhesion molecule. 
1990; Woo,  1990),  although  retinal  cells (Brackenbury et 
al.,  1977; Thiery et al.,  1977) and mouse neuroblastoma 
N2A cells (Rathjen and Rutishauser,  1984) aggregate vigor- 
ously by NCAM-dependent mechanisms.  Furthermore,  no 
homophilic  interaction  of soluble NCAM to immobilized 
NCAM was detected in a direct binding assay (Probstmeier 
et al.,  1989). Currently  it is unclear whether NCAM func- 
tions by binding to other NCAM molecules (homophilic  in- 
teractions),  to non-NCAM receptors (heterophilic  interac- 
tions),  or both. 
In addition to the extracellular  binding of an adhesion mol- 
ecule with its  ligand,  interaction  of the cytoplasmic por- 
tion of the adhesion molecule with intracellular  cytoskeletal 
elements  often is required to achieve  a  strong  and stable 
adhesive interaction.  Cell-extracellular  matrix adhesion me- 
diated by integrins and cell-cell adhesion mediated by cad- 
herins, for example, both require actin cytoskeleton involve- 
ment  for strong  adhesion  (Boiler et al.,  1985;  Volk and 
Geiger, 1986a,b; Hirano et al., 1987; Burridge et al., 1988; 
Nagafuchi  and Takeichi,  1988; Albelda and Buck,  1990). 
The involvement,  if any, of cytoskeletal systems in NCAM- 
mediated adhesion has not been defined. 
In  this  study  we examined  the  nature  of adhesion  to 
NCAM and the potential  involvement of the cytoskeleton in 
adhesion  using a centrifugal  cell-substratum binding  assay 
(McClay et al.,  1981; Lotz et al.,  1989) to determine the 
force required to dislodge adherent ceils from purified NCAM 
adsorbed to a solid substratum (Fig.  1). This assay provides 
a  more quantitative  measure of the  strength  of adhesion 
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(Brackenbury et al., 1977; Thiery et al., 1977; Brackenbury 
et al.,  1981).  Furthermore,  the centrifugation assay allows 
one adhesion system to be studied in isolation by immobiliz- 
ing a purified adhesion molecule (in this case NCAM) on a 
solid substratum. In contrast, ceU-cell binding experiments 
can be difficult to interpret because of the presence of multi- 
ple adhesion systems on the same cells (Bixby et al.,  1987; 
Neugebauer et al., 1988; Dustin and Springer, 1991). Simi- 
lar cell-substratum adhesion assays have been used to exam- 
ine cell adhesion to extracellular matrix molecules (McClay 
et al.,  1981; Lotz et al.,  1989; Lallier and Bronner-Fraser, 
1991) and to study cell-cell adhesion molecules involved in 
cellular interactions in the immune system (Springer, 1990; 
Dustin and Springer,  1991). 
Our experiments used two different cell types to examine 
NCAM-mediated adhesion. Chicken retinal cells taken from 
day 10 or 11 of development were prepared by treatment with 
low  concentrations  of  trypsin  in  the  presence  of  EDTA 
(Brackenbury  et  al.,  1981).  These  cells,  which  aggregate 
strongly by an NCAM-dependent mechanism, were used in 
the original characterization of NCAM-mediated adhesion 
03rackenbury et al., 1977; Thiery et al., 1977). Mouse N2A 
neuroblastoma cells are tissue culture cells that aggregate by 
an NCAM-mediated mechanism along with other calcium- 
independent mechanisms involving the L1  (NgCAM) glyco- 
protein (Rathjen and Rutishauser,  1984). 
The goals of this study were to characterize quantitatively 
the  adhesion of these  two  cell types  to  substratum-bound 
NCAM  and to  determine whether  NCAM-mediated cell- 
substratum binding is homophilic or heterophilic. The data 
support a heterophilic mode of adhesion of substrate-bound 
NCAM with as-yet unidentified ligand on the cell surface. 
Adhesion to NCAM was not impaired after pharmacological 
perturbation of the actin or tubulin cytoskeletons, suggesting 
that these cytoskeletal systems are not involved in adhesion 
to substratum-bound NCAM. 
Materials and Methods 
Antibodies 
Rabbit antibodies directed against purified chicken brain NCAM and mouse 
mAb Anti-NCAM No.  1 against chicken NCAM (Hoffman et al., 1982) 
were generous gifts of B. A. Cunningham and G. M. Edelman (The Rocke- 
feller University, New York). Rabbit antibodies also were obtained from 
C.-M. Chuong (University of Southern California, Los Angeles, CA). To 
produce mAbs, hybridoma cells (2 x  107 cells/animal) were injected in- 
trapetitoneally into female BALB/c mice (,06 wk old; Simonsen Laborato- 
ties, Gilroy, CA) that had been primed 3-7 d previously with a 0.5-mi in- 
traperitoneai  injection of Pristane  (2, 6,  10,  14-tetmmethylpentadecane; 
Sigma Chem. Co., St. Louis, MO). Ascites fluid was obtained 14-20 d later 
using  an  18-gauge needle  from  mice  anesthetized  by  inhalation  of 
methoxyflurane (Metofane; Pitman-Moore Inc., Mundelein, IL). Fluid was 
obtained at most twice from any one mouse; the mouse was killed by cervi- 
cal dislocation after light methoxyflurane anesthesia immediately before the 
second procedure. Crude IgG was prepared by precipitation from 50% satu- 
rated ammonium sulfate and was further purified by chromatography on 
staphylococcal protein A immobilized on Sepharose CL-4B (Sigma Chem. 
Co.) (Harlow and Lane,  1988). 
Fat/fragments of polyclonal and mnnoclonal antibodies were prepared 
by pepsin digestion as described by Brackenbury et al. (1977); residual in- 
tact IgG was removed by chromatography on protein A-Sepharose (Sigma 
Chem.  Co.).  Purity and completeness of digestion was verified by SDS- 
PAGE in 10% polyacrylamide gels (Laemmli,  1970) followed by staining 
with Coomassie brilliant blue R (Sigma Chem. Co.). 
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Figure L Schematic diagram of centrifugal adhesion assay. Purified 
substrate molecules are allowed to adsorb to nitxoceUulose-coated 
(stippled) polyvinyl  chloride wells (1). Radioactively labeled probe 
cells (3H-labeled, open circles; 14C-labeled,  closed circles) are al- 
lowed to settle into contact with the substratum for a given period 
of time (2), after which a second set of wells is inverted on top of 
the first to form a double-sided sandwich (3). The sandwich is in- 
verted and centrifuged at different speeds to remove nonadherent 
cells (4). Nonadbesive cells are detected as radioactivity that sedi- 
ments into the original  top well, whereas adhesive cells are detected 
as radioactivity that remains with the substratum (5). 
Purification of  NCAM 
Chicken retinal NCAM was purified from embryonic day 10-12 retinas by 
a modification of the method of Hoffman et al. (1982). mAb Anti-NCAM 
No. 1 was immobilized on AffiGel 10 beads (Bio-Rad Laboratories, Rich- 
mond,  CA) according to the  manufacturer's recommendations and was 
washed once with elution buffer (50 mM diethylamlne, pH 11, in PBS, be- 
fore use. Columns typically contained 2-3 ml of gel with an attached anti- 
body concentration of 5-20 mg/mi. Retinas (usually 40-50 per preparation) 
were homogenized in a 7-ml glass Dounce homogenizer in PBS containing 
2 % (vol/vol) Triton  X-100 (Sigma Chem. Co.) and 0.0108 TIU/mi aprofinin 
(Sigma Chem. Co.) as a protease inhibitor. The retinas were homogenized 
on ice using 20 strokes of the A pestle and insoluble material was removed 
by centrifngation at 18,000 g for 10 rain. The supernatant was passed over 
the mAb column four times in the cold and the column was washed with 
10 vol of the same buffer. The column then was sequentially washed with 
10 vol ofPBS + 0.1% "l~ton X-100 +  1 M NaC1 and 10 vol of PBS before 
being eluted with PBS + 50 mM diethylamine, pH 11.0.5-ml fractions were 
collected in tubes containing 0.1 rni 1 M potassium phosphate buffer, pH 
6,8, to neutralize the eluting solution and the eluted material was detected 
by absorbance at 280 rtm. NCAM  concentrations were estimated by assum- 
ing that a 1-mg/mi solution of NCAM has an absorbance of t at 280 ran. 
Purity of the eluted material was verified for each preparation by SDS- 
PAGE in a 6% gel followed by silver staining (Morrissey, 1981). 
Extracellular Matrix Molecules 
Human  plasma fibronectin was a gift from T. LaUier and M. Broaner-Fraser 
and was originally obtained from the New York Blood Bank (New York, 
NY).  Laminin was prepared by T. LaMer from the mouse  Engelbreth- 
Holm-Swarm sarcoma as described (Timpl et al., 1979). 
PAGE 
PAGE in the presence of SDS (Laemmli,  1970) was performed using a 
minigel apparatus (Bio-Rad Laboratories) according to the manufacturer's 
recommendations. After  electrophoresis,  gels  were  stained  either  with 
Coomassie brilliant  blue  or by a silver-staining procedure for enhanced sen- 
sitivity (Mortissey, 1981). 
Cell Culture and Transfection 
Mouse N2A neuroblastoma cells were obtained from the American Type 
Culture Collection (Rockville, MD; No. CCL 131) and routinely were cul- 
tured in DME (Irvine Scientific, Santa Aria, CA) containing 12.5% FBS 
(Irvine Scientific or HyClone Laboratories Inc., Logan, LIT). A mutant 
line of CHO ceils that is deficient in dihydrofolate reductase (Urlaub and 
Chasin,  1980; a generous gift of R. Johnston, University of Calgary, Al- 
berta,  Canada) was grown in the alpha modification of Eagle's minimal 
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cine, hypoxanthine, and thymidine to compensate for the tack of dihydrofo- 
late reductase. 
CHO  cells  were  cotransfected  by  a  calcium  phosphate  precipitation 
method (Davis et al.,  1986) with NCAM expression plasmids (Edetman et 
al.,  1987)  and the  MG4  plasmid  containing  a  functional  dihydrofolate 
reductase minigene as a selectable marker (Gasser et al.,  1982; Johnston 
and Kucey,  1988). Permanent transfectants expressing dihydrofolate reduc- 
tase were selected by growth in medium lacking glycine, hypoxanthine, and 
thymidine.  Cells  expressing  NCAM  were  detected  by  indirect  im- 
munoftnorescence using anti-NcAM polyclonal antibodies and monoclonal 
antibody Anti-NCAM No.  1 (Edelman et al.,  1987). Levels of binding of 
Anti-NCAM No.  1 to the surfaces of transfected cells were determined by 
flow cytometry using an EPICS V Flow Cytometer (Coulter Corp., Hia- 
leah, FL) in the Developmental Biology Center at the University of Califor- 
nia, Irvine. 
Cell Adhesion Assay 
Our procedures were based on those of McClay et al. (1981) as modified 
by Lotz et al.  (1989).  Substrata were prepared in strips cut from 96-well 
polyvinyl chloride flexible microtiter dishes (Falcon 3912; Fisher Scientific 
Co. Allied Corp., Los Angeles, CA). Substrata were coated with 5 ~l of 
a solution of nitrocellulose in methanol (BA-85, 5 cm  2 in 6  ml methanol; 
Schleicher &  Schull, Keena, NH) and were allowed to air dry (Lagenaur 
and Lemmon,  1987).  Substrate protein solutions (20 ~tl) were added and 
were allowed to adsorb at room temperature for 30 rain.  Liquid was re- 
moved by aspiration and 100 ~l blocking solution was added to each well 
to saturate unoccupied binding sites. Blocking solution contained 10 mg/mi 
BSA (RIA grade; Sigma Chem. Co.) dissolved in PBS; the solution was 
heat-inactivated by incubation at 56~  for 1 h and was then filtered through 
a 0.2-~m Nalgene membrane filter (Fisher Scientific Co., Allied Corp.). 
Blocking  solution  was  made  fresh  for  each  experiment  to  minimize 
nonspecific cell binding. After 1-2 h of blocking, the wells were washed 
once with PBS and once with adhesion buffer (80% Earle's balanced salts 
solution (Sigma Chem. Co.) +  20/~g/mi DNase I (type IV from bovine pan- 
creas; Sigma Chem. Co.) +  20% blocking solution to give a final BSA con- 
centration of 2 mg/ml). Wells were stored under 30 #l adhesion buffer until 
used in the assay.  Where indicated, antibodies were included in the final 
buffer incubation and were left on the substrata for at least 15 min before 
performing the assay. 
N2A and CHO probe cells were labeled by incubation overnight (12- 
17 h) in leucine-free medium containing 10% FBS +  1 #Ci/ml [3H]leucine 
or [14C]leucine (ICN Radiochemicals, Costa Mesa, CA). After the label- 
ing period, cultures were washed once with PBS and were incubated in com- 
plete label-free medium  for 2-4  h  to deplete  soluble pools.  Cells  were 
released from the dish by the low trypsin with EDTA procedure described 
by Brackenbury et al. (1981).  Briefly, cells were washed once with PBS and 
were  incubated  for 20 rain in divalent cation-free medium  (suspension 
modification of MEM;  Sigma Chem.  Co.) containing 1 mM EDTA,  20 
t~g/mi DNase I (type IV from bovine pancreas; Sigma Chem. Co.) and 20 
/zg/ml  purified  trypsin  (Sigma  Chem.  Co.).  Soybean  trypsin  inhibitor 
(Sigma Chem. Co.) then was added to 100 ~g/ml; the cells were recovered 
by gentle pipetting and dispersed by repeated pipetting on ice. Ceils were 
counted and achievement of a single cell suspension was verified microscop- 
ically using a hemocytometer. Cells were maintained on ice from this point 
until the assay was performed. 
Retinal probe cells were obtained from one or two retinas dissected from 
embryonic day 10-12 chickens. Cells were prepared using low trypsin with 
EDTA as described (Brackenbury et ai.,  1981). Retinal cells were labeled 
for 4 h in the dark with 10/tCi/ml[3H]leucine (McClay et ai.,  1981;  Lotz 
et ai.,  1989) before being washed and tested in the assay. 
Probe cells were diluted to a final concentration of 5  ￿  10  s cells/m1 (for 
retinal cells) or 5  x  104 cells/ml (for N2A and CHO cells). Differing cell 
numbers were used because the retinal cells were considerably smaller than 
the other two cell types. 50/tl aliquots (25,000 retinal cells or 2,500 N2A 
or CHO cells) were applied to each well and were allowed to settle onto 
the substratum at unit gravity for times and at temperatures appropriate for 
the particular experiment.  After this incubation,  the sample wells  were 
gently filled with adhesion buffer and a liquid-filled sandwich was assem- 
bled by inverting a  second strip containing adhesion buffer onto the ex- 
perimental strip. The sandwich was held together by a layer of double-sided 
carpet tape (Scotch No.  140; 3M Corp., St. Paul, MN) that had been ap- 
plied to the top strip; holes vcere burned into the strip at the positions of 
the  experimental  wells  with  a  heated  No.  3  brass  cork  borer  (Fisher 
Scientific Co.  Allied Corp.). 
The assembled sandwich was inverted gently and centrifuged (model 
CR.11, Jouan, Inc., Winchester, VA) at the indicated speeds for 8 min at 
4~  After the centrifngafion, wells containing bubbles (usually not more 
than one per eight-well strip) were noted and later were omitted from the 
data analysis. The sandwich was placed gently on a dry ice-ethanol bath 
for 30-60 s, inverted, and allowed to freeze completely. The ends of the 
top and bottom wells then were cut off into 5-mi scintillation vials (Beck- 
man Instrs., Inc., Fullerton, CA) using a modified pet nail clipper. 0.4 ml 
PBS  +  1%  (vol/vol) Triton X-100 was added to solubilize the cells and 
5  ml  water-compatible  scintillation fluid (SafetySolve;  ICes. Prod.  Intl. 
Corp., Mount Prospect, IL) was added to each vial. The vials were counted 
for 5 min in an LS3801 liquid scintillation counter (Beckman Instrs., Inc.) 
with windows adjusted for 3H/14C dual-label counting. Background radio- 
activity was measured using we/Is to which no probe cells had been added; 
this value was subtracted from each experimental point. Control samples 
contained wells into which aliquots of each labeled cell type had been cen- 
trifuged separately; these allowed calculation of the percent recovery of the 
added cells and of the spillover coefficients required to calculate the 3H 
counts for each sample. Typically 70-100% of the applied radioactivity was 
recovered. Percent adhesion was calculated as 
cpm in substrate welt 
x  100. 
clam in substrate well  +  cpm in top well 
Because absolute levels of adhesion to substratum-bound molecules var- 
ied somewhat from day to day,  the effects of experimental perturbations 
were compared in all cases to control samples included in the same experi- 
ment. Each figure presents the results of a representative experiment; the 
number of times a particular experiment was repeated with essentially the 
same relative results is given in the figure legend. Each experiment was per- 
formed at least twice. 
Proteoglycans 
Crude  retinal proteoglycans were prepared  according to the method of 
Bretscher (1985) by ion exchange chromatography of Triton X-100 extracts 
of embryonic  day  11  chick  retinas  (Burg  and  Cole,  1990)  on  DEAE- 
Trisacryl M (LKB Instruments, Inc., Gaithersburg, MD). Briefly, extracts 
were applied to the column in 0.15 M  NaCl,  0.01  M  Tris.HCl,  pH 8.0, 
5 mM MgSO4, 2% (vol/vol) Triton X-100, and 1 mM PMSE The column 
was washed sequentially with Triton-containing buffers containing 0.3 M 
NaC1, 8 M urea, 0.3 M sodium formate (pH 3.5) and 8 M urea, and 0.05 M 
Tris-HCl, pH 8.0. Protoaglycans were eluted with 1 M NaCt, 0.01 M Tris- 
HCI, pH 8.0, 0.01% (vol/vol) Triton X-100, and were dialyzed against 0.01 M 
Tris-HC1,  pH 8.0, 0.01%  (vol/vol) Triton X-100. 
Results 
Chicken Retinal Cells and Mouse N2A 
Neuroblastoma Cells Specifically Adhere to 
Substratum-bound NCAM 
Embryonic day 10 chicken retinal cells prepared by the low 
trypsin with EDTA procedure adhered well in the centrifugal 
adhesion  assay  to  chicken  retinal  NCAM  adsorbed  to  a 
nitrocellulose substratum  (Fig. 2 A).  Monovalent Fab' frag- 
ments prepared from anti-chicken NCAM polyclonal rabbit 
IgG, but not FalY fragments prepared from nonimmune IgG, 
completely inhibited this adhesion. Retinal cells did not ad- 
here significantly to a BSA-adsorbed substratum in the pres- 
ence or absence of antibodies. Consistent with the results of 
Hall et al. (1987),  retinal cells adhered weakly to fibronec- 
tin. Adhesion to fibronectin was not inhibited by anti-NCAM 
antibodies more than with nonimmune antibodies, demon- 
strating the specificity of the inhibition and showing that the 
initiation of adhesion by anti-NCAM antibodies does not re- 
suit solely from steric blockade of the cell surface NCAM 
on the retinal cells. Retinal cells do express NCAM, as was 
shown by their adhesion to the anti-chicken NCAM  mAb 
Anti-NCAM  No.  1 immobilized on the substratum;  this in- 
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Figure 2. Cell adhesion to substratum-adsorbed molecules. El0 chicken retinal  cells (,4) or mouse N2A neuroblastoma cells  (B) were 
labeled  with [3H]leucine and were applied  to the indicated  substrata.  After incubation at 37~  for 30 min, the ceils were subjected  to 
a removal force of 30 g for 8 min and percent adhesion was calculated.  Substrata were NCAM, 0.5 #g (A) or 1.4 #g (B) purified chicken 
retinal NCAM (25 #g/ml and 70 #g/ml coating concentrations); Anti-N,  1 #g mAb Anti-NCAM No. 1 (50 #g/ml coating concentration); 
Fn, 0.5 #g fibronectin  (25 #g/ml coating concentration); BSA, no additional  substratum protein (BSA blocking solution only). Error bars 
indicate  the range of duplicate determinations.  The results  of a representative  experiment are shown; three additional  experiments  gave 
essentially  the same results. 
teraction also was inhibited specifically by Anti-NCAM FalY 
fragments, presumably by blocking the NCAM expressed on 
the surface of the retinal  cells. 
Cultured  mouse N2A neuroblastoma  cells  also adhered 
well to immobilized chicken NCAM (Fig. 2 B). This adhe- 
sion was specifically inhibited by monovalent Fab' fragments 
of polyclonal  antibodies  directed  against  chicken  NCAM 
(Fig.  2  B) or by the adhesion-blocking mAb Anti-NCAM 
No.  1  directed  against  chicken  NCAM  (Hoffman  et  al., 
1982) (data not shown; but see Fig.  8 B).  As was the case 
for the retinal cells,  N2A cells did not adhere significantly 
to BSA; they adhered  to a  moderate extent to fibronectin, 
and that adhesion was unaffected by antibodies to NCAM. 
Similar results were obtained for adhesion to the extracellu- 
lar matrix protein laminin (data not shown; but see Figs. 4 
and 5). Mouse N2A cells did not adhere significantly to the 
mAb  Anti-NCAM  No.  1,  which  is  specific  for  chicken 
NCAM. 
The amount of force required  to remove adhering N2A 
cells varied with the density of NCAM adsorbed to the sub- 
stratum (Fig. 3 A). Increasing the concentration of NCAM 
applied to the substratum resulted in an increase in the force 
required to remove the ceils from the substratum.  Based on 
these data we used a  substrate  concentration of ,,ol  #g of 
NCAM applied per well and a removal force of 30 g to fur- 
ther characterize adhesion to NCAM. 
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Figure 3.  Adhesion of N2A cells  to NCAM at different  removal 
forces.  Dilutions  of a stock retinal  NCAM preparation (70 #g/ml) 
were applied  at 20 #l/well to nitrocellulose-coated dishes at final 
concentrations  of  1.4  #g/well  (solid  circles; undiluted),  0.42 
#g/well (open circles), 0.14 #g/well (solid squares), or no NCAM 
(open squares). N2A cells were labeled with [3H]leucine and were 
allowed to adhere for 15 min at 37~  (A) or 0 ~ (B) to the indicated 
concentrations of chick retinal  NCAM. Cells were then subjected 
to a removal force of  30 g for 8 min and percent adhesion was calcu- 
lated. Each point represents  a single well. The results of a represen- 
tative experiment are shown; three similar experiments  gave essen- 
tially the same results. 
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Figure 4. Effects of temperature and divalent cations on adhesion 
of N2A cells. Adhesion was carried out in the presence (solid bars) 
or absence (stippled bars) of divalent cations.  N2A cells were la- 
beled with pH]leucine and were allowed to adhere for 15 min at 
37~  (A) or 0 ~ (B) to the indicated substrata. Cells were then sub- 
jected to a removal force of 30 g for 8 rain and percent adhesion 
was calculated.  Substrata were NCAM, 0.64 #g purified chicken 
retinal  NCAM (32 #g/ml coating concentration); BSA, no addi- 
tional substratum protein (BSA blocking solution only); Lm, 0.5 #g 
laminin  (25 #g/ml coating concentration).  Error bars indicate  the 
range of duplicate  determinations.  The results  of a representative 
experiment are shown; two similar experiments gave essentially the 
same results. 
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Figure 5. Effects of cytoskele- 
ton-disrupting  drugs on N2A 
adhesion to NCAM substrata. 
Mouse  N2A  neuroblastoma 
cells were labeled with [3H]- 
leucine  and  were  applied  to 
the indicated substrata  in the 
presence of the indicated con- 
centrations  (0,  1,  or  10 #M) 
cytochalasin D (A) or colchi- 
cine (B).  After incubation at 
37~  for  30  min,  the  cells 
were  subjected  to a  removal 
force of 30 g for 8 min,  and 
percent  adhesion  was  calcu- 
lated. Substrata were NCAM, 
1.4/~g purified chicken retinal 
NCAM (70 #g/rnl coating con- 
centration); Laminin, 0.5 #g laminin (25 tLg/ml  coating concentration); BSA, no additional substratum protein (BSA blocking solution only). 
Error bars indicate the range of duplicate determinations. The results of a representative experiment are shown; three additional experiments 
with cytochalasin  D and one additional experiment with colchicine gave essentially the same results. 
Adhesion to NCAM Is Cation Independent 
but Temperature Dependent 
Many cell adhesion processes occur in two phases. The ini- 
tial phase involves a weak interaction, thought to result from 
the binding of the adhesion molecules themselves; this is fol- 
lowed by a  dramatic strengthening of the adhesion that in 
many cases involves interactions with the cytoskeleton (Um- 
breit  and  Roseman,  1975;  McClay  et  al.,  1981).  This 
strengthening can occur in as little as 5 min; it requires incu- 
bation at warm temperatures and the presence of metabolic 
energy. To see if a similar phenomenon occurs during adhe- 
sion to NCAM, we tested the effect of temperature on N2A 
cell adhesion in the centrifugation assay. Like adhesion to 
laminin,  NCAM-mediated adhesion was reduced dramati- 
cally at 0~  compared with 37~  (Figs.  3 B and 4). 
Neuroblastoma cells adhered well to NCAM in the pres- 
ence or absence of divalent cations (Fig. 4), confirming that 
NCAM is a calcium-independent adhesion molecule (Brack- 
enbury et al., 1977; Thiery et al., 1977; Brackenbury et al., 
1981). Adhesion to laminin, on the other hand, was inhibited 
in the absence of divalent cations.  Although the receptors 
responsible for N2A cell adhesion to laminin have not been 
defined,  such  adhesion  is  most likely  to  be mediated by 
members  of the  integrin  family  of cell  surface  proteins, 
whose  adhesive activities are cation dependent  (Fujimura 
and Phillips,  1983; Gailit and Ruoslahti,  1988; Albelda and 
Buck,  1990). 
Adhesion to NCAM Is Insensitive to Treatment With 
Colchicine or Cytochalasin D 
The strengthening  of adhesion to NCAM by incubation at 
37~  suggested that adhesion to NCAM,  like adhesion to 
laminin,  might involve the  cytoskeleton.  To test this,  we 
treated N2A cells with the microtubule inhibitor colchicine 
(Fig. 5 B) or the actin microfilament inhibitor cytochalasin 
D  (Fig. 5 A). Neither of these drugs significantly inhibited 
adhesion of N2A cells to purified NCAM. In fact, adhesion 
to NCAM appeared to be moderately increased in the pres- 
ence of cytochalasin D. In contrast, and consistent with the 
properties of integrin-mediated adhesion, adhesion of N2A 
cells to laminin was significantly inhibited by treatment with 
cytochalasin D  (Fig. 5 A) but not by treatment with colchi- 
cine (data not shown).  These experiments make it unlikely 
that adhesion to NCAM critically requires attachment to ac- 
tin microfilaments or to colchicine-sensitive microtubules. 
Cells Expressing Transfected NCAM Do Not Attach to 
Substratum-bound NCAM 
To  examine  further  the  mechanism  of  NCAM-mediated 
adhesion, we transfected CHO cells with full-length cDNA 
constructions  encoding  different  NCAM  protein  isoforms 
(Edelman et al.,  1987).  Because earlier experiments sug- 
gested  that  NCAM-mediated  adhesion  is  homophilic,  we 
anticipated that these cells would adhere specifically to sub- 
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N-CAM  Anti-N  Fn  BSA 
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Figure  6.  Adhesion  of transfected  CHO  cells  to  substratum- 
adsorbed  NCAM. 3H-labeled CHO transfectant IA6 (I) and 14C- 
labeled transfectant IIC6 (H) were allowed to adhere in the same 
wells to the indicated substrata for 15 min at 37~  and were then 
subjected to a removal force of 30 g for 8 min.  Substrata  were 
NCAM, 1.4 ~g purified chicken retinal NCAM (70 #g/ml coating 
concentration);  Anti-N, 1 #g mAb Anti-NCAM No.  1 (50 ftg/ml 
coating concentration);  Fn, 0.5 /zg fibronectin (25 #g/ml coating 
concentration); BSA, no additional substratum protein (BSA block- 
ing solution only). Error bars indicate the range of duplicate deter- 
minations. The results of a representative  experiment axe shown; 
one additional experiment  gave essentially the same results. 
Murray  and Jensen  Cell Adhesion  to Neural Cell Adhesion  Molecule  1315 stratum-bound NCAM. Surprisingly, no specific adhesion of 
these transfectants to adsorbed NCAM was observed (Fig. 
6). A few transfected lines adhered to some degree to puri- 
fied NCAM (for example, line 1 in Fig. 6), but this adhesion 
was completely insensitive to treatment with anti-NCAM an- 
tibody fragments, and we therefore concluded that it was not 
specific. Flow cytometric analysis using mAb Anti-NCAM 
No. 1 showed that the levels of NCAM expression at the sur- 
face of the transfected cells were comparable to those on 
chicken retinal cells, which bind well to these same substrata 
(data not shown).  These results are in agreement with our 
previous data  (Edelman et al.,  1987)  and those of others 
(Pizzey et al.,  1989)  indicating  that  cell-cell  adhesion of 
transfected cells is at best very weak and are inconsistent 
with a simple homophilic adhesion mechanism. In contrast, 
previous experiments have shown that neural retinal cells ex- 
hibit strong adhesion (Brackenbury et al.,  1977;  Thiery et 
al.,  1977)  and  suggest  that  NCAM-mediated  adhesion  is 
homophilic  (Rutishauser  et al.,  1982;  Hoffman and  Edel- 
man, 1983). Because the transfected cells express NCAM in 
an unnatural  context,  we decided therefore to test the ho- 
mophilic or heterophilic nature of NCAM adhesion in the 
cell substratum assay using cells that are known to aggregate 
using an NCAM-dependent mechanism. 
Adhesion Appears to Involve a Heterophilic 
Interaction of  Substrate-bound NCAM with a 
Non-NCAM Molecule on the Cell Surface 
There are at least two possible explanations that could ac- 
count  for  the  failure  of  transfected  cells  to  adhere  to 
substratum-adsorbed NCAM.  Some essential cofactor for 
adhesion may be supplied normally to NCAM in neural cells 
but not in CHO cells, or NCAM-mediated adhesion could 
in fact be heterophilic, i.e., involve binding to a ligand differ- 
ent from NCAM (Fig. 7). Under the latter hypothesis, trans- 
fected CHO cells would  lack the NCAM ligand  and thus 
would not aggregate.  If this were so,  then the adhesion of 
retinal cells and  N2A cells to NCAM  substrata would in- 
volve the postulated NCAM ligand, not cell surface NCAM, 
and antibody-mediated inhibition of cell surface (as opposed 
to substratum-bound) NCAM would have little or no effect 
on adhesion. 
To test this possibility, we treated N2A cells and NCAM- 
coated  substrata  separately  with  monovalent  anti-NCAM 
Figure 7.  Models of NCAM- 
mediated adhesion. (A) Sche- 
matic  diagram  of  cell-cell 
adhesion  mediated  by homo- 
philic  (top) or  heterophilic 
(bottom)  interactions  with 
NCAM.  (B)  Corresponding 
model of  cell adhesion to sub- 
stratum-bound  NCAM  by  a 
homophilic  (left) or  heter~ 
philic  (right)  mechanism. 
(Solid figure) NCAM;  (gray 
figure) NCAM ligand. 
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Figure & Inhibition of N2A adhesion by separate antibody treat- 
ment of cells and substrata.  (.4) Polyelonal anti-NCAM FalY frag- 
ments or nonimmune FalY  fragments were used as indicated to treat 
the indicated substrata  alone, cells alone, or both ceils and sub- 
strata together. (B) rnAb anti-NCAM No.  1 was used to treat the 
indicated substrata alone or the cells alone. Ceils were allowed to 
adhere to the substrata for 20 min at 37~  before being subjected 
to a removal force of 30 g for 8 min.  Substrata were NCAM, 0.5 
#g purified chicken retinal NCAM (25 #g/ml coating concentra- 
tion); Fn, 0.5/xg fibronectin (25 t~g/mt  coating concentration); BSA, 
no additional substratum protein (BSA blocking solution only). Er- 
ror bars indicate the range of duplicate determinations. The results 
of a representative experiment are shown; one additional experi- 
ment gave essentially the same results. 
Fab' fragments and washed away the unbound antibodies be- 
fore performing the centrifugafion assay (Fig. 8). Treatment 
of the substrata with anti-NCAM antibodies abolished adhe- 
sion of cells to NCAM but not to fibronectin, confirming that 
the substratum-adsorbed NCAM molecules were participat- 
ing in adhesion. Both polyclonal (Fig.  8 A) and monoclonal 
(Fig. 8 B) antibody fragments against NCAM were eff cfive. 
In  contrast,  treatment  of the  cells  with  polyclonal  anti- 
NCAM antibody fragments had no specific effect on adhe- 
sion to purified NCAM (Fig. 8 A). Similar results were ob- 
tained  for  adhesion  of retinal  cells  to  substratum-bound 
NCAM and fibronectin (Fig. 9 A). These results are most 
easily explained by postulating that the cell surface ligand for 
substratum-bound NCAM is not itself NCAM. As expected, 
treatment of N2A cells with anti-NCAM No. 1 did not affect 
adhesion; this antibody does not react with mouse NCAM. 
It is  possible that  the  lack of inhibition  of adhesion of 
antibody-coated cells was the result of antibody internaliza- 
tion or insertion of new NCAM onto the ce1! surface during 
the brief incubation at 37~C.  To test this, adhesion experi- 
ments were performed at 4~  where these processes should 
not be occurring but where retinal adhesion to substratum- 
bound NCAM, although weak, is still detectable. Similar ex- 
periments could not be performed with N2A cells because 
their adhesion is so weak at 4*C (Fig. 3 B). Treatment of the 
The Journal of Cel! Biology, Volume 117,  1992  1316 100 " 
80 
'~  60 
4~ 
40 
~.  2o 
A.  37  ~ Incubation 
1  2  3  4  5 
100 
8O 
g 
"~ 60 
.Iz 
~ 4o 
0 
B.  0 ~ Incubation 
1  2  5 
Retinal Cell 
Treatment: 
￿9  + nonimmune  Fab' 
[]  + anti-N-CAM  Fab' 
Figure 9. Inhibition of chick retinal cell adhesion by separate anti- 
body treatment of cells and substrata.  NCAM-adsorbed  substrata 
(0.4 #g/well,  20 #g/ml coating  concentration)  were treated  with 
nonimmune FalY  fragments (1) or polyclonal anti-NCAM Fab' frag- 
ments (2),  after which the unbound antibodies  were removed by 
washing. Control  wells (3) contained nonimmune (solid bars) or 
polyclonal anti-NCAM Fab' fragments (stippled bars) throughout 
the assay. Other wells contained  fibronectin (4) or BSA (5) sub- 
strata without added antibodies. Probe cells were treated in solution 
with nonimmune  (solid bars) or anti-NCAM (stippled bars) Fab' 
fragments, washed (except for 3), and brought into contact with the 
indicated substrata.  Cells were allowed to adhere to the substrata 
for 20 min at 37~  (A) or 0~  (B) before being subjected to a 
removal force of 30 g for 8 min. Error bars indicate the range of 
duplicate  determinations.  The results of a representative  experi- 
ment are shown. Two additional experiments at 37~  gave essen- 
tially the same results seen in A; further experiments at 0~  are de- 
scribed  in the legend to Fig.  10. 
retinal  cells  with  anti-NCAM  antibodies  had  no  specific 
effect on adhesion to NCAM substrata, whereas treatment of 
the substratum dramatically inhibited adhesion (Fig.  9 B). 
To characterize this adhesion further,  similar experiments 
were carried out using a range of removal forces (Fig.  10). 
Preincubating  the  retinal  cells  with  anti-NCAM  antibody 
fragments did significantly inhibit adhesion to NCAM (Fig. 
10,  A and B) but did not significantly inhibit adhesion to 
substratum-adsorbed Anti-NCAM No.  1 mAb (Fig.  10 C). 
The latter result showed that the antibody incubation proce- 
dure was effective in covering up the NCAM on the surface 
of the retinal cells. As before, incubation of the substratum 
with anti-NCAM antibody fragments significantly inhibited 
the adhesion of both antibody-treated and untreated retinal 
cells (compare Fig.  10 B with A). Antibody treatment had 
no effect on adhesion to the nonadhesive BSA-adsorbed con- 
trol substratum (Fig.  10 D).  These results suggest that the 
simple homophilic model of NCAM-mediated adhesion is 
inadequate.  Rather, they are consistent with the possibility 
that adhesion to substratum-bound NCAM involves a non- 
NCAM ligand on the retinal cell surface. 
The heterophilic ligand for NCAM is not known, although 
experiments of others  suggest that a  heparan  sulfate pro- 
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Figure I0.  Effect of removal force on chick retinal cell adhesion to 
NCAM at 4~  NCAM-adsorbed substrata (0.7 #g/well,  35 #g/ml 
coating  concentration)  were treated  with  nonimmune  FalY frag- 
ments  (A)  or polyclonal  anti-NCAM  FalY fragments  (B),  after 
which the unbound  antibodies were removed by washing. Other 
wells contained Anti-NCAM No. 1 mAb (1 #g/well, 50 #g/ml coat- 
ing concentration)  (C) or BSA (D) substrata without added anti- 
bodies. Embryonic day 12 retinal cells were treated in solution with 
nonimmune (closed circles) or anti-NCAM open circles) Fab' frag- 
ments, washed, and brought into contact with the indicated sub- 
strata by centrifugation at 17 g for 8 min at 4~  Cells were allowed 
to adhere to the substrata for 20 rain at 0~  before being subjected 
to the indicated removal forces for 8 min. Each symbol represents 
a single well. The results of a representative experiment are shown; 
two additional experiments gave essentially the same results. 
teoglycan may play this role (Cole et al., 1985,  1986a,b). In 
preliminary experiments, crude proteoglycans prepared from 
embryonic chicken retinal membranes did not support N2A 
cell or retinal cell adhesion when adsorbed to a nitrocellu- 
lose substrate, and incubation of these proteoglycans with an 
NCAM substrate inhibited cell adhesion (Fig.  11). This is 
consistent with previous work showing that heparin inhibits 
NCAM-mediated adhesion (Cole et al., 1985,  1986b; Reyes 
et al.,  1990) but does not support the hypothesis that adhe- 
sion to NCAM is mediated by a heparan sulfate ligand. How- 
ever, it is possible that the crude proteoglycan preparations 
used for these experiments might contain both adhesive and 
inhibitory components, so further experimentation will be 
required to resolve this point definitively. 
Discussion 
The experiments reported here demonstrated that adhesion 
to substratum-bound NCAM can be measured quantitatively 
by a centrifugal removal assay (McClay et al.,  1981; Lotz et 
al., 1989). Purified substratum-bound NCAM mediated cell 
adhesion,  supporting the view that NCAM acts directly as 
an adhesive ligand between cells rather than a facilitator or 
cofactor  for  other  cellular  systems.  The  results  further 
demonstrated that the strength of adhesion increased with in- 
creasing concentrations of NCAM on the substratum.  The 
specificity of the adhesion was supported by its inhibition by 
polyclonal anti-NCAM Fab' fragments and by an mAb that 
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Figure H. Effects of  retinal proteoglycans on cell-substratum adhe- 
sion.  Wells were coated with purified chicken NCAM (NCAM, 
0.6/*g/well, 30/*g/ml coating concentration), fibronectin (Fn, 0.5 
/,g/well,  25 /*g/ml coating concentration),  or blocking solution 
alone (BSA). Proteoglycans were prepared from embryonic day 11 
chicken retinas (Bretscher, 1985) and were applied (20/*l/well, ab- 
sorbance at 280 nm= 0.1) directly to nitrocellulose substrata (PG) 
or to substrata that had previously been coated with chicken retinal 
NCAM and blocked with BSA (NCAM + PG). After extensive 
washing of the substrata, mouse N2A cells or El3 chicken retinal 
cells were labeled and allowed to adhere to the substrata for 25 min 
at 37~  The cells were then subjected to a removal force of 30 g 
for 8 min and percentage adhesion was measured. Error bars indi- 
cate the range of duplicate determinations. The results of a repre- 
sentative experiment are shown; two additional experiments gave 
essentially the same results. 
inhibited NCAM-mediated adhesion in suspension adhesion 
assays.  These experiments confirm and extend the work of 
Cole and co-workers (Cole and Glaser,  1984; Cole et al., 
1985; Reyes et al., 1990), who used a different assay to show 
that retinal cells can bind to substratum-adsorbed NCAM, 
and extend the binding results to N2A neuroblastoma cells. 
The use of purified NCAM in a cell-substratum binding 
assay had the advantage of isolating the analysis of NCAM- 
mediated adhesion from other adhesive systems present on 
the  same  cells.  This  is  particularly  significant  because 
cell-cell binding  studies  have demonstrated that  multiple 
adhesion systems, including those involving NCAM,  con- 
tribute in an apparently redundant fashion to the adhesive in- 
teractions between neurons, glia, and muscle cells (Bixby et 
al.,  1987;  Neugebauer et al.,  1988). The presence of such 
multiple  adhesion  systems  may  have  contributed  to  the 
difficulty of identifying NCAM-mediated adhesion in earlier 
cell monolayer adhesion experiments using retinal cells and 
transfected fibroblasts (Woo,  1990). 
The adhesion of N2A cells and retinal cells to laminin and 
to NCAM both were greatly strengthened by incubation of 
the cells with the substratum at 37~  Both adhesion systems 
were  insensitive  to  colchicine treatment,  suggesting  that 
microtubules are not required for either. However, unlike the 
adhesion of N2A cells to laminin, adhesion to NCAM did 
not require divalent cations and was unaffected by treatment 
with cytochalasin D, which disrupts the actin cytoskeleton. 
The cation-independent nature  of NCAM-mediated  adhe- 
sion in this assay system is consistent with the original defini- 
tion of NCAM as a calcium-independent adhesion molecule 
(Rutishauser et al.,  1976; Brackenbury et al.,  1977; Thiery 
et al., 1977). These results imply that different mechanisms 
underlie adhesion to laminin and to NCAM.  In particular, 
the insensitivity to divalent cation deprivation and to cyto- 
chalasin treatment suggests that the NCAM ligand is not an 
integrin. This is of interest because there are several exam- 
pies in the immune system in which integrins act as cell sur- 
face  adhesion  receptors  for  immunoglobulin  superfamily 
members with structural  similarities to NCAM  (Springer, 
1990; Dustin and Springer,  1991). 
Although  interactions  with  the  actin  cytoskeleton ap- 
peared not to be involved in adhesion to NCAM, the adhe- 
sion did strengthen upon incubation at 37~  This might 
reflect strengthening  by  diffusion of cell  surface NCAM 
ligands  in  the plane of the membrane into the  region of 
cell-substratum  contact  and  consequent  interaction  with 
substrate  bound  NCAM  or  possibly  an  interaction  with 
cytoskeletal elements not sensitive to the inhibitors used in 
this study. Adhesive strengthening by membrane diffusion of 
adhesion molecules has been suggested to occur for calcium- 
dependent retinal cell adhesion in the presence of metabolic 
poisons (McClay et al.,  1981) and for the adhesion of lym- 
phoid cell lines to substratum-adsorbed LFA-3 through cell 
surface CD2 molecules (Chan et al., 1991). The latter work- 
ers  reported a  moderate strengthening .of cell-substratum 
adhesion in the presence of cytochalasin, similar to that seen 
in the experiments reported here. 
It is difficult to distinguish homophilic from heterophilic 
adhesion in cell-ceU adhesion assays in suspension.  Both 
homophilic and heterophilic cell aggregation should be in- 
hibited by anti-NCAM antibodies because NCAM is a criti- 
cal component of every adhesive bond under both models 
(Fig. 7). The use of a cell-substratum adhesion assay, on the 
other hand,  allows one to separate experimentally the two 
halves  of the  adhesive interaction and  thus to  determine 
whether the partner for substratum-adsorbed NCAM is an- 
other NCAM molecule on the adhering cell (Fig. 7). The use 
of the centrifugal adhesion assay thus allowed us to test the 
homophilic or heterophilic nature of NCAM binding in a 
more direct fashion than has been possible in the past. 
Our  antibody blocking experiments  supported a  heter- 
ophilic binding mechanism for adhesion to substratum-bound 
NCAM. Coating of cell surface NCAM molecules with anti- 
NCAM antibodies failed to inhibit the adhesion of the cells 
to substratum-bound NCAM,  although it did inhibit their 
adhesion to substratum-bound mAb's that are known to rec- 
ognize cell surface NCAM. These results are difficult to in- 
terpret in the context of a simple homophilic interaction be- 
tween substratum-bound and cell surface NCAM molecules; 
rather they support a heterophilic adhesion model in which 
substratum-adsorbed NCAM binds to a non-NCAM ligand 
on the surface of the adhering cell. 
Earlier experiments showed that separate incubation of 
anti-NCAM  antibodies  with  cells  in  suspension  or  with 
substrate-attached cells could significantly inhibit adhesion 
(Rutishauser et al., 1982). These results were interpreted to 
support  the  homophilic  adhesion model.  However,  since 
each adhesion partner presumably would carry both NCAM 
and its ligand, such a result also could be explained under 
the heterophilic model by weakening only of the adhesive 
bonds using the NCAM molecules on the targeted cells. This 
might suffice to allow the shear forces in the cell monolayer 
binding assays to inhibit retention of the probe cells on the 
monolayers. 
Nevertheless, the current experiments do not rule out an 
additional,  weaker NCAM  to NCAM  adhesion,  although 
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in direct binding experiments of others (Probstmeier et al., 
1989).  Vesicle  aggregation  experiments  using  purified 
NCAM and lipids supported the hypothesis of homophilic 
NCAM binding (Hoffman and Edelman,  1983; Hall et al., 
1990) and weak cell-cell adhesion was observed with some 
NCAM  transfectants  (Edelman et al.,  1987;  Pizzey et al., 
1989); these results might reflect a weak homophilic interac- 
tion in the absence of a stronger heterophilic  ligand.  Thus 
it  is  possible  that  NCAM  might  exhibit  multiple  binding 
specificities,  as do a  number of other cell  surface and ex- 
tracellular matrix adhesive molecules.  For example,  the Ig 
superfamily member ICAM-1  (Rothlein et al.,  1986) binds 
to different  ligands (LFA-1  and Mac-l)  through Ig-like do- 
mains  1 and 3, respectively  (Diamond et al.,  1991). 
What might the heterophilic NCAM ligand or ligands be? 
The results presented here suggest that the NCAM ligand is 
not an integrin. Probstmeier et al. (1989) found that purified 
NCAM bound to several species of collagen, suggesting that 
collagen  might  act  as  an  NCAM  ligand  in  cell  adhesion; 
however, in preliminary experiments we were not able to de- 
tect specific  adhesion of transfected CHO cells to purified 
collagens  I,  H, IV,  V,  or VI (data not shown). 
Our results also failed to support a role for heparan sulfate 
proteoglycans in adhesion to NCAM, although several previ- 
ous studies suggest that a heparan sulfate proteoglycan is an 
attractive candidate for an NCAM ligand. Heparin and hepa- 
ran sulfate are known to bind to NCAM (Cole et al.,  1986a) 
and to inhibit NCAM-mediated adhesion (Cole et al.,  1985; 
Cole et al.,  1986b) and a putative heparin binding domain 
of  NCAM  is  required  for  adhesion  of  retinal  cells  to 
substratum-bound NCAM (Reyers et al.,  1990). However, it 
has not been shown directly that a heparan sulfate proteogly- 
can serves as an NCAM adhesive ligand, and no such adhe- 
sion was detected in the current study. On the other hand, 
proteoglycans isolated from neural tissues, including the em- 
bryonic  chicken  retinal  proteoglycans  used in the current 
study, comprise a complex mixture including several differ- 
ent heparan sulfate-bearing and chondroitin sulfate-bearing 
protein cores (Cole and Burg,  1989; Burg and Cole,  1990). 
This raises the possibility that inhibitory proteoglycan spe- 
cies  present  in  this  mixture  might  mask  the  adhesion- 
promoting activities of an NCAM proteoglycan ligand. Fur- 
ther studies of separated proteoglycan species isolated from 
retinal tissue will be required to resolve this point. 
The physiological ligand or ligands for NCAM thus cannot 
be identified yet with any degree of certainty.  It should be 
possible to use the centrifugal adhesion assay along with the 
transfected cells expressing NCAM polypeptides both to test 
purified potential ligands for their ability to mediate attach- 
ment through cell  surface NCAM and to purify additional 
ligand candidates  from cell  membrane extracts.  It will be 
necessary to identify and characterize the NCAM ligand or 
ligands to define the physiological role of NCAM in vivo and 
to determine whether control of expression of the ligand, as 
well as of NCAM itself, is significant for the control of cellu- 
lar adhesive activities  in the intact organism. 
We thank Drs. B. A. Cunningham, G. M.  Edelman, and C.-M, Chuong 
for polyclonal and monoclonal antibodies against chicken NCAM; Dr. R. 
Johnston for CHO cells and the MG4 plasmid; and Drs. T. Lallier and M. 
Bronner-Fraser  for  fibronectin  and  laminin.  We  thank  Scott  Storms, 
Thomas Lallier, and Marianne Bronner-Fraser for a critical reading of the 
manuscript. 
This work was supported by grant CD-416 from the American Cancer 
Society. 
Received for publication 27 January 1992 and in revised form 11 March 
1992. 
References 
Albelda, S. M., and C. A. Buck. 1990, Integrins and other cell adhesion mole- 
cules. FASEB  (Fed. Am.  Soc. Exp. Biol.)  J.  4:2868-2880. 
Bixby, J. L., R. S. Pratt, J. Lilien, and L. F. Reichardt.  1987.  Neurite out- 
growth on muscle cell  surfaces involves extracellular matrix receptors as 
well as Ca2+-dependent  and -independent cell adhesion molecules. Proc. 
Natl. Acad.  Sci. USA. 84:2555-2559. 
Boiler,  K.,  D.  Vestweber,  and R.  Kemler.  1985.  Cell  adhesion molecule 
uvomorulin is localized in the intermediate junctions of adult intestinal epi- 
thelial cells. J.  Celt BioL 100:327-332. 
Brackenbury, R., J.-P. Thiery, U, Rutishauser, and G. M.  Edelman.  1977. 
Adhesion among neural cells of the chick embryo. I. An immunological as- 
say for molecules involved in cell-cell binding. J. Biol. Chem. 252:6835- 
6840. 
Brackenbury, R., U. Rutishauser, and G. M. Edelman. 1981. Distinct calcium- 
independent and calcium-dependent adhesion systems of chicken embryo 
cells. Proc.  Natl. Acad. Sci. USA. 78:387-391. 
Bretscher, M. S.  1985.  Heparan sulphate proteoglycans and their polypeptide 
chains from BHK cells. EMBO (Eur. Mol. Biol. Organ.)J.  4:1941-1944. 
Burg, M., and G. J. Cole. 1990. Characterization of cell-associated proteogly- 
cans synthesized  by embryonic neural retinal cells. Arch. Biochem. Biophys. 
276:396-404. 
Burridge, K., K. Fath, G. Kelley, G. Nuckolts, and C. Turner.  1988.  Focal 
adhesions: transmembrane  junctions  between the extracellular matrix and the 
cytoskeleton. Annu.  Rev. Cell BioL 4:487-525. 
Chart, P. Y., M. B. Lawrence, M. L. Dustin, L. M. Ferguson, D. E. Golan, 
and T. A. Springer. 199 I. Influence of receptor lateral mobility on adhesion 
strengthening  between membranes  containing LFA-3 and CD2. J. Cell Biol. 
115:245-255. 
Cole, G. J., and M. Burg.  1989.  Characterization of a heparan sulfate pro- 
teoglycan that copurifies with the neural cell adhesion molecule. Exp. Cell 
Res.  182:44-60. 
Cole, G. J., and L. Glaser. 1984. Cell-substratum  adhesion in embryonic chick 
central  nervous system is mediated by a  170,000-mol-wt neural-specific 
polypeptide. J.  Cell Biol. 99:1605-1612. 
Cole, G., D. Schubert, and L. Glaser. 1985. Cell-substratum  adhesion in chick 
neural retina depends upon protein-heparan sulfate interactions. J. Cell Biol. 
100:1192-1199. 
Cole, G. J., A. Loewy, N. V. Cross, R. Akeson, and L. Glaser. 1986a. Topo- 
graphic localization of  the heparin-binding  domain of the neural cell adhesion 
molecule N-CAM. J.  Cell Biol. t03:I739-1744. 
Cole, G. J., A. Loewy, and L. Glaser. 1986b. Neuronal cell-cell  adhesion de- 
pends  on  interactions of N-CAM  with  heparin-like  molecules.  Nature 
(Lond.).  320:445-447. 
Crossin, K.L., C.-M.  Chuong, and G.  M.  Edelman.  1985.  Expression se- 
quences of cell adhesion molecules. Proc. Natl. Acad.  Sci. USA. 82:6942- 
6946. 
Davis, L. G., M. D. Dibner, and J. F. Battey.  1986. Basic Methods in Molecu- 
lar Biology. Elsevier Science Publishing Co., Inc., New York.  388 pp. 
Diamond, M. S.,  D. E. Staunton, S. D. Marlin, and T. A. Springer.  1991. 
Binding of the integrin Mac- 1 (CD 11 b/CD 18) to the third immunoglobulin- 
like domain of ICAM-1 (CD54) and its regulation by glycosylation, Cell. 
65:961-971. 
Dustin, M. L., and T. A. Springer. 1991. Role of lymphocyte adhesion recep- 
tors in transient interactions and cell  locomotion. Annu. Rev. Immunol. 
9:27-66. 
Edelman, G. M., B. A. Murray, R.-M. Mege, B. A. Cunningham, and W. J. 
Gallin.  1987. Cellular expression of liver and neural cell adhesion molecules 
after transfection with  their cDNAs results in specific  cell-cell binding. 
Proc. NatL  Acad. Sci. USA. 84:8502-8506. 
Fraser, S. E., B. A. Murray, C.-M. Chuong, and G. M. Edelman. 1984. Alter- 
ations of  the retinotectal map in Xenopus by antibodies to neural cell adhesion 
molecules. Proc. Natl. Acad. Sci.  USA. 81:4222--4226. 
Fujimura, K., and D. Phillips. 1983. Calcium cation regulation ofglycoprotein 
llb/IIIa complex formation in platelet  plasma membranes. J.  Biol. Chem. 
258:10247-10252. 
Gailit, J., and E. Ruoslahti. 1988. Regulation of the fibronectin receptor affinity 
by divalent cations. J.  Biol. Chem. 263:12927-12932. 
Gasser, C. S., C. C. Simonsen, J. W. Schilling, and R. T. Schimke. 1982. Ex- 
pression of abbreviated  mouse dihydrofolate reductase genes in cultured 
hamster ceils. Proc. Natl.  Acad. Sci. USA. 79:6522-6526. 
Hall, D. E., K. M. Neugebaner, and L. F. Reichardt. 1987. Embryonic neutral 
retinal cell response to extracellular matrix proteins: developmental changes 
and effects of the cell substratum attachment antibody (CSAT). J. Cell BioL 
Murray and Jensen Cell Adhesion  to Neural Cell Adhesion  Molecule  1319 104:623-634. 
Hall,  A.  K.,  R.  Nelson,  and U.  Rutishauser.  1990.  Binding properties of 
detergent-solubilized NCAM. J.  Cell Biol.  110:817-824. 
Harlow, E., and D. Lane. 1988. Antibodies: a laboratory manual. Cold Spring 
Harbor Laboratory, Cold Spring Harbor, NY. 726 pp. 
Hirano,  S.,  A.  Nose,  K.  Hatta,  A.  Kawakami,  and  M.  Takeichi.  1987. 
Calcium-dependent  cell-cell  adhesion  molecules  (cadherins):  subclass 
specificities  and  possible  involvement of  actin  bundles.  J.  Cell  Biol. 
105:2501-2510. 
Hoffman, S., and G. M. Edelman. 1983. Kinetics of homophilic binding by em- 
bryonic and adult forms of the neural cell adhesion molecule. Proc. Natl. 
Acad.  Sci. USA. 80:5762-5766. 
Hoffman, S., B. C. Sorkin, P. C. White, R. Brackenhury, R. Mailhammer, U. 
Rutishanser, B. A. Cunningham, and G. M. Edelman. 1982. Chemical char- 
acterization  of a neural cell adhesion molecule purified from embryonic brain 
membranes. J.  Biol. Chem. 257:7720-7729. 
Johnston, R. N., and B. L. Kucey. 1988. Competitive inhibition ofhsp70 gene 
expression causes thermosensitivity. Science (Wash. DC). 242:1551 - 1554. 
Kadmon, G., A. Kowitz, P. Altevogt, and M. Schachner. 1990. The neural cell 
adhesion molecule N-CAM enhances Ll-dependent cell-cell interactions. J. 
Cell Biol.  110:193-208. 
Keihaner, G., A. Faissner, and M. Schachner. 1985.  Differential  inhibition of 
neurone-neurone, neurone-astrocyte  and astrocyte-astrocyte adhesion by L 1, 
L2 and N-CAM antibodies.  Nature  (Loud.). 316:728-730. 
Laemmli, U. K.  1970. Cleavage of structural proteins during the assembly of 
the head of bacteriophage T4. Nature  (Loud.). 227:680-685. 
Lagenaur, C., and V. Lemmon. 1987. An Ll-like molecule, the 8D9 antigen, 
is a  potent substrate for neurite extension. Proc.  Natl. Acad. Sci. USA. 
84:7753-7757. 
Lallier, T., and M. Bronner-Fraser. 1991.  Avian neural crest cell attachment 
to laminin: involvement of divalent cation dependent and independent inte- 
grins. Development  (Camb.).  113:1069-1085. 
Lotz, M., C. Burdsal, H. Erickson, and D. McClay. 1989.  Cell adhesion of 
fibronectin and tenascin: quantitative  measurements of initial  binding and 
subsequent strengthening response. J.  Cell Biol. 109:1795-1805. 
McClay, D. R., G. M. Wessel, and R. B. Marchase. 1981. Intercellular recog- 
nition:  quantitation of initial  binding events. Proc.  Natl. Acad, Sci. USA. 
78:4975-4979. 
Morrissey, J.  H.  1981.  Silver stain for proteins in polyacrylamide gels:  a 
modified procedure  with  enhanced uniform sensitivity. Anal. Biochem. 
117:307-310. 
Nagafuchi, A., and M. Takeichi. 1988. Cell binding function of E-cadherin is 
regulated by the cytoplasmic domain. EMBO  (Eur. Mol, Biol. Organ.) J, 
7:3679-3684. 
Neugebauer, K. M., K. J.  Tomaselli, J.  Lilien, and L. F. Reichardt.  1988. 
N-cadherin, NCAM, and integrins promote retinal neurite outgrowth on as- 
trocytes in vitro. J.  Cell Biol. 107:1177-1187. 
Pizzey, J. A., L. H. RoweR, C. H. Barton, G. Dickson, andF. S. Walsh. 1989. 
Intercellular adhesion mediated by human muscle neural cell adhesion mole- 
cule: effects of alternative exon use. J.  Cell Biol. 109:3465-3476. 
Pollerberg, E. G., R. Sadoul, C. Goridis, and M. Schachner. 1985. Selective 
expression of the 180-kD component of the neural cell adhesion molecule 
N-CAM during development. J.  Cell Biol. 101:1921-1929. 
Probstmeier, R., K. Kuhn, and M. Schachner. 1989. Binding properties of the 
neural cell adhesion molecule to different  components of the extracellular 
matrix. J.  Neurochem.  53:1794-1801. 
Rathjen, F. G., and U. Rutishauser. 1984. Comparison of two cell surface mol- 
ecules involved in neural cell adhesion. EMBO (Eur. Mol. Biol. Organ.) J. 
3:461-465. 
Reyes, A. A., R. Akeson, L. Brezina, and G. J. Cole. 1990. Structural  require- 
merits for neural cell adhesion molecule-heparin interaction.  Cell Regula- 
tion.  1:567-576. 
Rothlein, R., M. L. Dustin, S. D. Marlin, and T. A. Springer. 1986. A human 
intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J. lmmunol. 
137:1270-1274. 
Rutishanser, U., J.-P. Thiery, R. Brackenhury, B.-A. Sela, and G. M. Edel- 
man. 1976.  Mechanisms of adhesion among cells from tissues of the chick 
embryo. Proc. Natl. Acad.  Sci. USA. 73:577-581. 
Rutishauser, U., S. Hoffman, and G. M. Edelman. 1982.  Binding properties 
of a cell adhesion molecule from neural tissue. Proc. Natl. Acad. Sci. USA. 
79:685-689. 
Rutishauser, U., M. Grnmet, and G. M. Edelman. 1983. Neural cell adhesion 
molecule mediates initial interactions between spinal cord neurons and mus- 
cle cells in culture. J.  Cell Biol. 97:145-152. 
Rntishauser, U., A. Acheson, A. K. Hall, D. M. Mann, andJ. Sunshine. 1988. 
The neural cell adhesion molecule (NCAM) as a regulator of cell-cell inter- 
actions. Science  (Wash. DC). 240:53-57. 
Sadoul, R., M. Him, H. Deagostini-Baziu, G. Rougon, and C. Goridis. 1983. 
Adult and embryonic mouse neural cell adhesion molecules have different 
binding properties. Nature  (Loud.). 304:347-349. 
Springer,  T.  A.  1990.  Adhesion receptors of the intmune system. Nature 
(Loud.).  346:425-434. 
Thiery, J.-P.,  R. Brackenhury, U. Rutishauser, and G.  M.  Edeman.  1977. 
Adhesion among neural cells of the chick embryo. II. Purification  and char- 
acterization of a cell adhesion molecule from neural retina. J. Biol. Chem. 
252:6841-6845. 
Thiery, J.-P., J.-L. Duband, U. Rutishauser, and G. M. Edelman. 1982. Cell 
adhesion molecules in early chicken embryogenesis. Proc. Natl. Acad. Sci. 
USA. 79:6737-6741. 
Thor, G., R. Probstmeier, and M. Schachner. 1987. Characterization of the cell 
adhesion molecules L1, N-CAM and J1 in the mouse intestine. EMBO (Fur. 
Mol. Biol. Organ.) J.  6:2581-2586. 
Timpl, R., H. Rohde, P. G. Robey, S. 1. Rennard, J.-M. Foidart, and G. R. 
Martin. 1979. Lamiuin-a glycoprotein from basement membranes. J. Biol. 
Chem. 254:9933-9937. 
Umbreit, J., and S. Roseman. 1975. A requirement for reversible binding be- 
tween aggregating embryonic cells before stable adhesion. J.  Biol. Chem. 
250:9360-9368. 
Urlaub, G., and L. A. Chasin. 1980. Isolation of Chinese hamster cell mutants 
deficient  in dihydrofolate reductase activity. Proc.  Natl. Acad.  Sci. USA. 
77:4216-4220. 
Volk, T., and B. Geiger.  1986a.  A-CAM: a  135-kd receptor of intercellular 
adherens  junction. I. Immunoelectron  microscopic localization  and biochem- 
ical studies. J.  Cell Biol. 103:1441-1450. 
Volk, T., and B. Geiger.  1986/7. A-CAM: a  135-kd receptor of intercellular 
adherens junction. If. Antibody-mediated modulation of  junction formation. 
J.  Cell Biol.  103:1451-1464. 
Woo, M. K. 1990. N-CAM mediated adhesion of transfected cells. Ph.D. the- 
sis. University of California, Irvine. 83 pp. 
The Journal of Cell Biology,  Volume 117,  1992  1320 